Should You Buy Marijuana Stocks Now That Pot Shops Are Legal in Ontario??

Marijuana stores just became legal in Ontario. Here’s how marijuana stocks like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stand to benefit.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

It’s official: brick-and-mortar cannabis shops are legal in Ontario.

As of Monday, Ontario’s first marijuana shops are open for business–and so far, business is booming. According to early reports, eager cannabis buyers have been lining up for hours to get their first taste of store-bought cannabis.

Although the lineups weren’t as long as those seen in other provinces on legalization day last year, they were sizable: according to CTV News, 60 people were lined up outside London’s Central Cannabis store for its 9am grand opening.

There are clear signs that cannabis shops are receiving a warm welcome in Ontario. The question is, will this last? Although perpetually high demand at Ontario cannabis shops would undoubtedly drive cannabis revenue higher, it’s not clear that the demand we’re seeing will last forever.

There’s a “novelty” effect that kicks in whenever a new product becomes available, and while online cannabis sales have been legal in Ontario since October, it’s possible that the novelty of buying weed in-store contributed to early demand.

To understand whether Ontario’s new pot shops will make pot stocks worth buying, we need to look at what happened after marijuana was legalized nationwide.

The legalization effect

On October 17, 2018, marijuana was legalized across Canada. This event was expected to dramatically increase marijuana growers’ revenue–and it did, with Canopy Growth Corp (TSX:WEED)(NYSE:CGC) selling 7300 kilograms of recreational cannabis in Q3.

On the other hand, there is some evidence that increased recreational sales are hurting cannabis companies’ margins. In Aphria Inc’s (TSX:APHA)(NYSE:APHA) Q2 report, gross margin declined, reportedly because the lower selling price of recreational cannabis drove overall selling prices lower.

Prior to legalization, I had written a number of articles speculating that the less-regulated recreational market could see lower margins than medical pot, and it looks like those concerns came to pass. Medical marijuana has much more compliance than recreational marijuana, meaning that there are more barriers to entry.

In a relatively free market, commodities like weed become almost perfectly competitive, and that’s precisely what we’re seeing in recreational cannabis. I might add that this was seen in Colorado, which legalized recreational cannabis in 2014 and saw its weed drop in price shortly thereafter.

Sales boost from in-store purchases

The start of brick-and-mortar cannabis sales in Ontario will likely drive cannabis revenues higher. Although the province has long had online cannabis sales, the convenience of in-store sales is new to the country’s largest cannabis market.

In the wake of legalization, it was reported that many Ontario pot aficionados opted to stay with their black market dealers rather than buy legal weed. It’s quite possible that the wait time involved in online cannabis purchases contributed to that. If so, the new Ontario cannabis stores will gain business from black market holdouts.

Canopy’s advantage

If any marijuana stock could benefit from Ontario’s brick-and-mortar cannabis store rollout, it’s Canopy Growth. Canopy has the most robust brick-and-mortar cannabis retail pipeline of all the major producers, with several branded retail stores like Tweed and Tokyo Smoke.

This gives them a big edge in the cannabis sales war, as other growers depend on third-party vendors to sell their product. Canopy is already planning on opening a Tokyo Smoke store in Toronto, demonstrating that it’s ready to grow its retail presence in the era of legal brick-and-mortar weed sales.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »